MCK
What one share of McKESSON holds
Wholesale – Drugs, Proprietaries and Druggists' Sundries
McKesson Corporation together with its subsidiaries (collectively, the “Company,” “McKesson,” “we,” “our,” or “us” and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.
McKESSON’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3,354 |
|---|---|
| Profit | $37.48 |
| Capex (buildings and equipment) | $3.57 |
| Free cash flow | $52.36 |
| Dividends | $3.28 |
| Cash and investments | $44.29 |
| Debt | $83.45 |
| Book value | −$36.37 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2008 | $341.29 | $3.32 | $0.65 | $2.26 | $0.24 | $21.03 |
| 2009 | $382.19 | $2.95 | $0.70 | $4.14 | $0.48 | $23.27 |
| 2010 | $398.18 | $4.63 | $0.73 | $7.75 | $0.48 | $27.75 |
| 2011 | $426.17 | $4.57 | $0.89 | $8.00 | $0.72 | $28.64 |
| 2012 | $487.33 | $5.59 | $0.88 | $10.87 | $0.80 | $29.02 |
| 2013 | $511.28 | $5.60 | $1.01 | $9.38 | $0.80 | $31.20 |
| 2014 | $589.67 | $5.42 | $1.19 | $12.27 | $0.92 | $36.96 |
| 2015 | $761.89 | $6.28 | $1.60 | $11.64 | $0.96 | $34.55 |
| 2016 | $819.24 | $9.69 | $2.09 | $13.67 | $1.08 | $39.66 |
| 2017 | $890.28 | $22.74 | $1.81 | $19.46 | $1.12 | $52.61 |
| 2018 | $996.92 | $0.32 | $1.94 | $18.85 | $1.30 | $48.52 |
| 2019 | $1,086 | $0.17 | $2.16 | $18.30 | $1.51 | $42.61 |
| 2020 | $1,272 | $4.96 | $1.99 | $22.09 | $1.62 | $31.46 |
| 2021 | $1,483 | −$28.26 | $2.81 | $25.47 | $1.67 | −$0.13 |
| 2022 | $1,713 | $7.23 | $2.52 | $26.26 | $1.83 | −$15.63 |
| 2023 | $1,946 | $25.04 | $2.74 | $33.54 | $2.09 | −$13.69 |
| 2024 | $2,304 | $22.39 | $3.21 | $28.96 | $2.40 | −$15.16 |
| 2025 | $2,803 | $25.72 | $4.19 | $43.31 | $2.75 | −$16.58 |
| 2026 | $3,251 | $38.37 | $3.51 | $46.08 | $3.17 | −$18.07 |